V2 Financial group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,256
Closed -$212K 59
2023
Q2
$212K Buy
+2,256
New +$176K 0.15% 58
2022
Q1
Sell
-2,776
Closed -$216K 65
2021
Q4
$216K Sell
2,776
-340
-11% -$30K 0.17% 66
2021
Q3
$297K Buy
3,116
+455
+17% +$48K 0.26% 48
2021
Q2
$331K Sell
2,661
-39
-1% -$4.66K 0.28% 46
2021
Q1
$356K Buy
+2,700
New +$370K 0.32% 42

Other funds holding EXAS

V2 Financial group's EXAS Position: Q3 2023 in Review

V2 Financial group sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 2,256 shares — an estimated $212K sold.

V2 Financial group first reported a position in EXAS in Q1 2021 and held it in 5 quarters. The position peaked at $356K in Q1 2021. 624 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

  • V2 Financial group reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
  • V2 Financial group sold 2,256 Exact Sciences shares in Q3 2023, an estimated $212K.
  • V2 Financial group first reported a position in Exact Sciences in Q1 2021 and held it in 5 quarters.
  • V2 Financial group's Exact Sciences position peaked at $356K in Q1 2021.
  • 624 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on V2 Financial group's 13F filing for Q3 2023, filed 10 May 2024.